Company / Cash & Equivalents
Greater Cannabis Company, Inc. Cash & Equivalents History
FY2017-FY2022 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Cash & Equivalents
$270.0K
FY2022
5-year range
$24.7K / $377.5K
FY2018-FY2022
Trend
-28.5%
vs FY2021
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Cash & Equivalents has fluctuated over the past 6 years, ranging from $993 in FY2017 to $377,520 in FY2021.
Based on SEC 10-K filings.
$270,030 in FY2022 with a 5-year CAGR of +206.8%.
Improved from $112,953 to $270,030 over the past 2 years.
Cash & Equivalents over time
Growth rates
- 3-Year CAGR
- +122.1%
- 5-Year CAGR
- +206.8%
- 10-Year CAGR
- -
Key checks
Key Insights
- 5-year CAGR of +206.8%, indicating consistent growth.
- In FY2022, cash & equivalents decreased 28.5% year-over-year.
- Peak cash & equivalents was recorded in FY2021.
- Lowest cash & equivalents in the period was in FY2017.
Company context
Key Data Points
- Altman Z-Score -16.62 (distress zone, below 1.23 threshold)
- Piotroski F-Score: 2/9 criteria passed
- Cash-backed earnings: Operating cash flow exceeds net income
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Cash & EquivalentsValue | YoY GrowthYoY |
|---|---|---|
| FY2022 | $270.0K | -28.5% |
| FY2021 | $377.5K | +234.2% |
| FY2020 | $113.0K | +358.0% |
| FY2019 | $24.7K | -58.8% |
| FY2018 | $59.9K | +5931.3% |
| FY2017 | $993 | - |